Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded an excellent growth through diversification and process improvements. Having state-of-the-art US FDA & EUGMP approved facility; Concord is a professionally managed globally recognised supplier of fermentation based API’s and enzyme & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing.
The existing portfolio of products includes API’s in the immunosuppressant, antibiotic, Oncology , Anti-Obesity, hypolipemic segments and enzymes. However, with the expertise in the field of biotechnology and chemistry, the R&D team at Concord is working towards adding new products to the product basket.
Location: India, Gujarat, Ahmedabad
Employees: 501-1000
Founded date: 2000
Investors 1
| Date | Name | Website |
| - | Quadria Ca... | quadriacap... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 08.08.2023 | NIIT Learning valued at Rs 5,000 cr; Concord Biotech IPO sub... | NIIT Learning valued at Rs 5,000 cr on debut Shares of NIIT Learning Systems—demerged from NIIT—fin... | business-s... |
| 31.07.2023 | Jhunjhunwala-backed Concord Biotech eyes to raise Rs 1,550 c... | Ahmedabad-based Concord Biotech, makers of fermentation-based bulk drugs, is aiming to raise between... | business-s... |
| 24.12.2021 | Mahindra Homes Private Limited announces an Equity Buyback f... | Mahindra Homes Private Limited announces a share repurchase program. Under the program, the company ... | marketscre... |
| 22.09.2015 | London-based PE firm Actis Capital in talks to buy minority ... | Premium London-based private equity firm Actis Capital is in discussions to buy a significant minor... | dealstreet... |